- Home
- NVCT vs BDTX Comparison
NVCT vs BDTX Comparison
Compare NVCT & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- BDTX
- Stock Information
- Founded
- NVCT 2020
- BDTX 2014
- Country
- NVCT United States
- BDTX United States
- Employees
- NVCT N/A
- BDTX N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NVCT Health Care
- BDTX Health Care
- Exchange
- NVCT Nasdaq
- BDTX Nasdaq
- Market Cap
- NVCT 130.6M
- BDTX 126.2M
- IPO Year
- NVCT 2022
- BDTX 2020
- Fundamental
- Price
- NVCT $7.59
- BDTX $2.16
- Analyst Decision
- NVCT Strong Buy
- BDTX Strong Buy
- Analyst Count
- NVCT 1
- BDTX 4
- Target Price
- NVCT $21.00
- BDTX $15.50
- AVG Volume (30 Days)
- NVCT 133.8K
- BDTX 567.4K
- Earning Date
- NVCT 03-04-2025
- BDTX 03-11-2025
- Dividend Yield
- NVCT N/A
- BDTX N/A
- EPS Growth
- NVCT N/A
- BDTX N/A
- EPS
- NVCT N/A
- BDTX N/A
- Revenue
- NVCT N/A
- BDTX N/A
- Revenue This Year
- NVCT N/A
- BDTX N/A
- Revenue Next Year
- NVCT N/A
- BDTX N/A
- P/E Ratio
- NVCT N/A
- BDTX N/A
- Revenue Growth
- NVCT N/A
- BDTX N/A
- 52 Week Low
- NVCT $4.44
- BDTX $1.91
- 52 Week High
- NVCT $12.10
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- NVCT 62.94
- BDTX 42.32
- Support Level
- NVCT $7.38
- BDTX $2.24
- Resistance Level
- NVCT $8.13
- BDTX $2.47
- Average True Range (ATR)
- NVCT 0.66
- BDTX 0.16
- MACD
- NVCT 0.05
- BDTX -0.03
- Stochastic Oscillator
- NVCT 76.72
- BDTX 5.69
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.